International Multicentre Prevalence Study on Sepsis

Overview

To mark 10 years of the Surviving Sepsis Campaign (SSC), and timed to coincide with World Sepsis Day, on September 13, 2013, the SSC, ESICM and SCCM will be conducting an international point prevalence study of severe sepsis and septic shock. The goal of this project is to determine the world wide burden of severe sepsis and define current practices of sepsis care internationally. The study is a simple data collection exercise for patients presenting with either severe sepsis or septic shock on World Sepsis Day.

Full Title of Study: “Surviving Sepsis Campaign. International Multicentre Prevalence Study on Sepsis.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: November 2013

Detailed Description

De—identified patient—level data will be collected on patients presenting to a participating intensive care unit or emergency department with severe sepsis or septic shock over a 24 hour period from 00:00 to 24:00 November 07, 2013. De—identified data that is already collected as part of routine clinical care will be collected for this study. Data to be collected includes hospital and ICU characteristics, patient characteristics, severity of illness, and adherence to SSC bundle elements and mortality. It will take between 30—60 minutes to collect and enter data for each patient admitted with severe sepsis or septic shock over the 24 hours study period.

Clinical Trial Outcome Measures

Primary Measures

  • 28-Day Mortality
    • Time Frame: one week

Secondary Measures

  • Organ Failure
    • Time Frame: one week

Participating in This Clinical Trial

Inclusion Criteria

To be eligible patients must have all of the following:

  • Must be admitted or transferred to either the ED or an Intensive Care Unit. – Have a high clinical suspicion of an infection – Have sepsis as defined by an infection together with two or more SIRS criteria – Evidence of acute organ dysfunction and/or Shock. Exclusion Criteria:

  • Patients less than 18 years of age – Patients in whom the sepsis has been present from before the beginning of the study period – Any patients previously included in the study during the same study period

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • European Society of Intensive Care Medicine
  • Collaborator
    • Society of Critical Care Medicine (SCCM)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Andrew RHODES, MD, PhD, Principal Investigator, European Society of Intensive Care Medicine

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.